The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

New Three-Times-Weekly Dose of Copaxone Now Available

by Elizabeth Davis on January 30, 2014 at 10:06 am

Good news for multiple sclerosis (MS) patients taking Copaxone (glatiramer acetate)—the FDA has approved a new three-times-weekly dose. The new dose will still be a subcutaneous injection, but will have a higher concentration at 40 mg/ml. Copaxone is currently available as 20 mg/ml injection, taken once daily. The new strength is approved in addition to the lower daily dose, and will not replace it.

The approval was based on a study that showed the 40 mg/ml dose given three times weekly reduced relapse rates by as much as 1/3 at twelve months, compared with a placebo.

The three-times-weekly 40 mg/ml strength of Copaxone will be available in pharmacies within days. There are several other new MS treatments recently approved, so you may want to discuss with your doctor which option is best for you.


Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on GoodRx.com are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.